Sulfonylureas are a well-established class of oral medications used to manage type 2 diabetes mellitus in the UK. Many men with diabetes experience erectile dysfunction and may wonder whether their diabetes medication could be contributing to this problem. Whilst sulfonylureas such as gliclazide and glimepiride are not recognised as causing erectile dysfunction directly, understanding the relationship between diabetes treatment and sexual health is important. This article examines the evidence surrounding sulfonylureas and erectile dysfunction, explores why ED is common in men with diabetes, and outlines effective management strategies to help you maintain both good diabetes control and sexual wellbeing.

Understanding Sulfonylureas and Their Role in Diabetes Management

Sulfonylureas are a well-established class of oral medications used to manage type 2 diabetes mellitus. They have been prescribed for over 60 years and remain an important treatment option. Licensed sulfonylureas in the UK include gliclazide (preferred), glimepiride, glipizide, glibenclamide and tolbutamide.

These medications work by stimulating the pancreatic beta cells to release more insulin. Specifically, sulfonylureas bind to ATP-sensitive potassium channels on the surface of beta cells, causing depolarisation and subsequent calcium influx, which triggers insulin secretion. This mechanism helps lower both fasting and post-prandial blood glucose levels, and can reduce HbA1c by approximately 1–2% when used appropriately.

NICE guidelines (NG28) recommend sulfonylureas as a treatment option for type 2 diabetes in several scenarios: as monotherapy when metformin is contraindicated or not tolerated, as a first intensification option with metformin, or as part of further treatment intensification. They are generally well-tolerated, though patients should be aware of potential adverse effects. The most significant risk is hypoglycaemia (low blood sugar), particularly in elderly patients, those with renal or hepatic impairment, or those with irregular eating patterns. Weight gain is also commonly observed, as increased insulin secretion promotes glucose storage.

Other side effects may include gastrointestinal disturbances, skin reactions, hyponatraemia, and rarely, haematological abnormalities. Patients taking sulfonylureas should be counselled about recognising hypoglycaemia symptoms—such as sweating, tremor, confusion, and palpitations—and the importance of regular meals. They should also understand precautions regarding alcohol consumption and driving. Despite these considerations, sulfonylureas remain a valuable option in diabetes management when used under appropriate medical supervision.

Can Sulfonylureas Cause Erectile Dysfunction?

The relationship between sulfonylureas and erectile dysfunction (ED) is not straightforward, and there is no official direct link established between these medications and sexual dysfunction. Unlike some other drug classes—such as certain antihypertensives or antidepressants—sulfonylureas are not recognised as having a direct pharmacological mechanism that would impair erectile function.

Current evidence from clinical studies and post-marketing surveillance data does not identify erectile dysfunction as a common or characteristic adverse effect of sulfonylurea therapy. The MHRA (Medicines and Healthcare products Regulatory Agency) and product information for sulfonylureas such as gliclazide and glimepiride do not list ED as a known side effect. This suggests that if any association exists, it is likely indirect rather than a direct consequence of the medication's action.

However, it is important to recognise that diabetes itself is a major risk factor for erectile dysfunction, affecting a significant proportion of men with the condition. The mechanisms linking diabetes to ED include vascular damage, neuropathy, hormonal changes, and psychological factors—all of which are consequences of the underlying disease rather than its treatment. Therefore, men with diabetes taking sulfonylureas who experience erectile dysfunction are more likely experiencing a complication of their diabetes rather than a side effect of the medication.

That said, some indirect effects of sulfonylurea therapy could theoretically contribute to sexual health concerns, though evidence for this is limited. Weight gain associated with these medications may affect body image and confidence, whilst hypoglycaemic episodes can cause anxiety and impact quality of life. Additionally, the psychological burden of managing a chronic condition like diabetes can itself contribute to sexual difficulties. If you are taking a sulfonylurea and experiencing erectile dysfunction, it is essential to discuss this with your healthcare provider to identify the underlying cause and explore appropriate management options.

If you suspect any medication may be causing side effects, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Why Erectile Dysfunction Occurs in People with Diabetes

Erectile dysfunction is significantly more prevalent in men with diabetes compared to the general population, and understanding the underlying mechanisms is crucial for effective management. Diabetes-related ED is multifactorial, involving vascular, neurological, hormonal, and psychological components.

Vascular damage is perhaps the most significant contributor. Chronic hyperglycaemia (elevated blood glucose) damages the endothelium—the inner lining of blood vessels—leading to atherosclerosis and reduced blood flow. Achieving and maintaining an erection requires adequate blood flow to the penile arteries and corpus cavernosum. When these vessels are compromised by diabetic vascular disease, erectile function is impaired. This process is similar to how diabetes increases cardiovascular disease risk throughout the body.

Diabetic neuropathy (nerve damage) is another major factor. Diabetes can damage the autonomic nerves responsible for the involuntary processes involved in erection, including the release of nitric oxide, which is essential for smooth muscle relaxation and blood vessel dilation in penile tissue. Peripheral neuropathy may also reduce penile sensation, further affecting sexual function.

Hormonal imbalances are common in men with diabetes. Studies show that men with type 2 diabetes often have lower testosterone levels (hypogonadism), which can reduce libido and contribute to erectile difficulties. In type 2 diabetes, sex hormone-binding globulin (SHBG) is typically reduced, which affects total testosterone measurements. Assessment of morning testosterone levels on two separate occasions is important for diagnosis of hypogonadism.

Psychological factors should not be overlooked. Living with diabetes can cause stress, anxiety, and depression—all of which are known contributors to sexual dysfunction. Performance anxiety, particularly after experiencing initial erectile difficulties, can create a cycle that perpetuates the problem. Furthermore, relationship issues and reduced self-esteem related to chronic illness management may compound these difficulties.

Other contributors to ED in men with diabetes include comorbidities such as hypertension, dyslipidaemia, and obstructive sleep apnoea, as well as medications used to treat these conditions (such as some antihypertensives). Recognising these multiple contributing factors is essential for developing a comprehensive treatment approach.

Managing Erectile Dysfunction While Taking Sulfonylureas

If you are taking a sulfonylurea and experiencing erectile dysfunction, several evidence-based management strategies can help, and it is unlikely that stopping your diabetes medication will be necessary or advisable. Optimising diabetes control is the foundation of managing ED in this context. Better glycaemic control can slow or even partially reverse some of the vascular and neurological damage contributing to erectile dysfunction. Aim to maintain your HbA1c within the target range agreed with your healthcare team. NICE guidance suggests targets of 48 mmol/mol (6.5%) for those not on medications causing hypoglycaemia, or 53 mmol/mol (7%) for those taking sulfonylureas or insulin, though individualised targets are important.

Lifestyle modifications play a crucial role and align with general diabetes management principles:

• Regular physical activity improves cardiovascular health, enhances blood flow, and can boost testosterone levels

• Weight management reduces insulin resistance and may improve erectile function

• Smoking cessation is vital, as smoking significantly worsens vascular function

• Limiting alcohol consumption can improve both diabetes control and sexual function

• Stress reduction techniques such as mindfulness or counselling may address psychological contributors

Pharmacological treatments for erectile dysfunction are generally safe and effective for men with diabetes. Phosphodiesterase-5 (PDE5) inhibitors are first-line treatments. Sildenafil is routinely available on NHS prescription for men with diabetes experiencing ED, while other options like tadalafil and vardenafil may require a 'Selected List Scheme' (SLS) endorsement. These medications work by enhancing the natural erectile response to sexual stimulation. They are generally safe to use alongside sulfonylureas, though you should inform your doctor of all medications you are taking. Important cautions include:

• PDE5 inhibitors must not be used with nitrate medications (prescribed for angina) or riociguat

• Use with caution if you are taking alpha-blockers for hypertension or prostate conditions

• Seek urgent medical attention for erections lasting more than 4 hours (priapism)

Other treatment options include vacuum erection devices, intracavernosal injections, or intraurethral therapy, which may be considered if oral medications are ineffective or contraindicated. Testosterone replacement therapy may be appropriate if blood tests confirm hypogonadism (low testosterone on two morning measurements), but should only be initiated with specialist input. Your GP or a specialist can discuss these options and help determine the most suitable approach for your individual circumstances.

When to Speak to Your GP About Sexual Health Concerns

Many men feel embarrassed discussing erectile dysfunction, but it is important to recognise that ED is a common medical condition, particularly among men with diabetes, and your GP is well-equipped to help. You should consider speaking to your healthcare provider if:

• You experience persistent or recurrent difficulty achieving or maintaining an erection sufficient for sexual activity

• Erectile problems are causing distress, anxiety, or relationship difficulties

• You notice a sudden change in erectile function, which could indicate worsening diabetes control or cardiovascular issues

• You have concerns about whether your medications might be contributing to sexual difficulties

• You experience other symptoms alongside ED, such as reduced libido, fatigue, or mood changes, which might suggest hormonal imbalances

• You have penile pain or curvature (which may indicate Peyronie's disease)

Your GP will typically conduct a thorough assessment, including a review of your diabetes control (HbA1c), cardiovascular risk factors, current medications, and lifestyle factors. They may arrange blood tests including morning total testosterone (measured between 8-11am on two occasions), luteinising hormone (LH), follicle-stimulating hormone (FSH), and possibly prolactin and thyroid function. A cardiovascular assessment is important because erectile dysfunction can be an early warning sign of heart disease, as the smaller penile arteries may show damage before larger coronary vessels.

Healthcare professionals increasingly recognise that sexual function is an important aspect of holistic diabetes care. Your GP can discuss treatment options, which may include lifestyle modifications, adjusting diabetes medications if appropriate, prescribing PDE5 inhibitors, or referring you to specialist services such as urology or endocrinology if needed. Referral may be particularly appropriate if you have complex cardiovascular disease, persistent ED despite first-line treatment, suspected hypogonadism, or penile deformity.

Remember that addressing erectile dysfunction is not merely about sexual function—it is an important aspect of overall health, quality of life, and may provide insights into your cardiovascular and metabolic health. Early discussion and intervention typically lead to better outcomes, so do not delay seeking help if you have concerns.

Frequently Asked Questions